21 – 30 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
- Contribution to journal › Article
-
Mark
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
- Contribution to journal › Article
-
Mark
Strong Binding of C-Glycosylic1,2-Thiodisaccharides to Galectin-3─Enthalpy-Driven Affinity Enhancement by Water-Mediated Hydrogen Bonds
Lázár, László ; Tsagkarakou, Anastasia S ; Stravodimos, George ; Kontopidis, George ; Leffler, Hakon LU ; Nilsson, Ulf J LU
; Somsák, László
and Leonidas, Demetres D
(2023)
In Journal of Medicinal Chemistry
66(17).
p.12420-12431
- Contribution to journal › Article
-
Mark
Discovery of Selective and Orally Available Galectin-1 Inhibitors
Zetterberg, Fredrik R ; Diehl, Carl LU ; Håkansson, Maria LU ; Kahl-Knutson, Barbro LU ; Leffler, Hakon LU ; Nilsson, Ulf J LU
; Peterson, Kristoffer
LU
; Roper, James A
and Slack, Robert J
(2023)
In Journal of Medicinal Chemistry
66(24).
p.16980-16990
- Contribution to journal › Article
-
Mark
Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds
Mahanti, Mukul LU ; Pal, Kumar Bhaskar ; Kumar, Rohit LU ; Schulze, Markus ; Leffler, Hakon LU ; Logan, Derek T LU
and Nilsson, Ulf J
LU
(2023)
In Journal of Medicinal Chemistry
66(21).
p.14716-14723
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor : a single- and multiple-dose first-in-human study in healthy participants
Aslanis, Vassilios ; Slack, Robert J. ; MacKinnon, Alison C. ; McClinton, Catherine ; Tantawi, Susan ; Gravelle, Lise ; Nilsson, Ulf J. LU
; Leffler, Hakon
LU
; Brooks, Ashley
and Khindri, Sanjeev K.
, et al.
(2023)
In Cancer Chemotherapy and Pharmacology
91(3).
p.267-280
- Contribution to journal › Article
- 2022
-
Mark
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
- Contribution to journal › Article
-
Mark
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Zetterberg, Fredrik R. ; Mackinnon, Alison ; Brimert, Thomas ; Gravelle, Lise ; Johnsson, Richard E. ; Kahl-Knutson, Barbro LU ; Leffler, Hakon LU ; Nilsson, Ulf J. LU
; Pedersen, Anders
and Peterson, Kristoffer
LU
, et al.
(2022)
In Journal of Medicinal Chemistry
65(19).
p.12626-12638
- Contribution to journal › Article
-
Mark
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia
Bum-Erdene, Khuchtumur ; Collins, Patrick M. ; Hugo, Matthew W. ; Tarighat, Somayeh S. ; Fei, Fei ; Kishor, Chandan ; Leffler, Hakon LU ; Nilsson, Ulf J. LU
; Groffen, John
and Grice, I. Darren
, et al.
(2022)
In Journal of Medicinal Chemistry
65(8).
p.5975-5989
- Contribution to journal › Article
-
Mark
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside
Girardi, Benedetta ; Manna, Martina ; Van Klaveren, Sjors LU ; Tomašič, Tihomir ; Jakopin, Žiga ; Leffler, Hakon LU ; Nilsson, Ulf J. LU
; Ricklin, Daniel
; Mravljak, Janez
and Schwardt, Oliver
, et al.
(2022)
In ChemMedChem
17(3).
- Contribution to journal › Article